extended subsequently. Editors now have organisations for discussing issues of policy in both Europe (European Association of Science Editors2) and the USA (Council of Biology Editors), and it seems probable that at a meeting to be held in Australia next month a similar organisation will be formed for that part of the world. In turn this should mean that the members of the international committee are better placed to make recommendations on future policies. Given that the format of references has been established, then, there are many opportunities, for example, for standardising abbreviations, making recommendations about what constitutes dual publication, and encouraging the use of SI units in those countries that have not adopted them. Nobody is suggesting that there should be any conformity in facts or opinion-rather the reverse, since the existence of conventions frees both authors and editors to concentrate on content-but one thing is clear: the present system whereby each editor chooses his own variation in reference style is wasteful, unnecessary, and has no advantages. Authors should pressurise editors to adopt a style which has been well thought out, is already used by many major journals, and which works.
STEPHEN LOCK Early claims for the efficacy of palliative radiotherapy7 were weakened by poor trial design and inconsistent administration of chemotherapy to some patients. One early prospective double-blind controlled study from the Mayo Clinic8 compared the effect of moderate doses of radiation (35-37 grays (Gy) or 3500-3700 rads) with that of a combination of radiotherapy and 5-fluorouracil in 64 patients with locally unresectable tumours. The group receiving combination treatment had a longer mean survival time (10.4 months) than their counterparts receiving radiation plus placebo (6-3 months), and radiation alone was thought unlikely to have had any influence on survival. More recently, Moertel and colleagues9 have reported a prospective randomised comparison of high-dose radiotherapy (60 Gy (6000 rads)) alone, moderate-dose radiotherapy (40 Gy (4000 rads)) plus 5-fluorouracil, and high-dose radiotherapy (60 Gy) plus fluorouracil in the treatment of unresectable pancreatic cancer. All their patients had histological confirmation of the diagnosis, were without evidence of distant metastases at laparotomy, and had regional disease encompassed by a 400-cm2 radiation field. Seven institutions took part in the trial and 194 patients were available for assessment. Radiotherapy was given in two-week courses of 20 Gy (2000 rads) with a two-week rest period between them. The 5-fluorouracil was given as an intravenous bolus on the first three days of each course of radiotherapy and thereafter was given weekly for two years or until progression of the tumour was evident. Nausea and vomiting were common complications, though seldom severe; marrow depression was also common (particularly when 5-fluorouracil was combined with radiotherapy), but mucocutaneous complications were rare.
Radiotherapy alone proved inferior to either combination of radiotherapy and chemotherapy and was abandoned after 106 patients had been entered. Though patients randomised to receive high-dose radiotherapy with 5-fluorouracil had a longer median interval before tumour progression (33.7 versus 23-3 weeks) and a longer median survival (49.4 versus 36-5 weeks) than their counterparts receiving moderate-dose radiation with 5-fluorouracil, neither difference was statistically significant; and by 15 months the two groups had overlapping survival curves. As 5-fluorouracil has very weak activity against pancreatic adenocarcinoma and as its administration did not appear to affect the frequency with which distant metastases were the first indication of recurrence, the authors suggest that its primary effect was enhancement of the local effect of radiotherapy.
These results were achieved in patients with locally unresectable pancreatic cancer without overt distant metastasesa clinical picture found in about one-third of patients at diagnosis. Moertel Profe.ssor J C McDonald, for example, showed dose-response curves for lung cancer in workers exposed to the safest and most widespread fibre, chrysotile, that were compatible with a linear relationship between fibre dose and cancer incidence and with no threshold of risk-though the risk would become very small, and he agreed that the data could be interpreted in other ways. Moreover, we lack the knowledge of the carcinogenic mechanisms that might put a brake on speculation. Nevertheless, there are many certainties about the dangers of asbestos, especially crocidolite; and several speakers drew attention to the shameful neglect of the messages of the 1964 New York conference on the biological effects of asbestos. The same controversies were being repeated. On the other hand while the 1964 conference had naively looked only for good science the Montreal symposium was at least more realistic in giving time to the industrial, socioeconomic, and political issues. Indeed, Mr Julian Peto's appeal for points of scientific controversy to be debated in depth until differences were resolved seemed doomed to fail; for despite the many excellent scientific reviews and the time given to discussion no consensus ever seemed likely to emerge.
Attended by nearly 700 participants from 49 countries, with a large international press contingent, the symposium was said to be the first of its kind on the subject of asbestos, covering a wide span of interests and experience and including representatives of government, industry, and labour as well as virtually all the key scientists. One recurring theme was "Asbestos can be used safely"-with a profound split in attitudes, from the industrialist who said, "We must stop talking about the results of the bad practices of 30 years ago now that asbestos is used responsibly and safely, and often in modified forms" to the American trade unionist who took the view that things were now worse than ever since more asbestos was in use, that controls were so far useless since there were no means of enforcing them, and that there should be a moratorium on asbestos use until safe working practices could be implemented. A meeting of this size, however, can achieve little true dialogue between those with opposing views; while as for working out guidelines for governments, such a gathering could add little to the various exhaustive reports of recent years, such as the British3 and the EEC`documents.
Some messages, however, came out of the meeting. Firstly, the general view was that with current standards rigorously enforced there should be virtually no health effects, and that the need was for proper enforcement wherever asbestos was used. As Dr Irving Selikoff said, producers and manufacturers deserved credit for the great improvements brought about by technology; the greater problem was to bring under control the more incidental uses and exposures. He had recently seen, for example, men engaged in repairs to asbestos-containing structures who had no masks or respirators and no instructions about safe practice. Secondly, Dr Selikoff emphasised the importance of keeping past workers under surveillance (a difficult task, seldom accomplished) and of urging them not to smoke, a measure that could substantially reduce the number of deaths since smoking multiplies the risk of lung cancer in those exposed. Thirdly, some countries, including developing nations, had much lower standards than those taken for granted in the West.
The political and economic aspects of asbestos are far more complex than is sometimes assumed: to think in terms of a ruthless industry versus an exploited workforce would be a considerable distortion. In Quebec, for example, the chrysotile mines and mills make a substantial contribution to the economy and provide much-needed employment. Developing nations rely on asbestos cement and pipes for cheap and durable building materials and would suffer considerably if they had to use more expensive substitutes. Thus many interests coincide in promoting the safe use of asbestos-if, indeed, that is possible.
